Molecular therapies and precision medicine for hepatocellular carcinoma

JM Llovet, R Montal, D Sia, RS Finn - Nature reviews Clinical oncology, 2018 - nature.com
The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass
an annual incidence of 1 million cases. Genomic studies have established the landscape of …

The evolving scenario in the assessment of radiological response for hepatocellular carcinoma in the era of immunotherapy: Strengths and weaknesses of surrogate …

P Giuffrida, C Celsa, M Antonucci, M Peri, MV Grassini… - Biomedicines, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is a challenging malignancy characterised by clinical and
biological heterogeneity, independent of the stage. Despite the application of surveillance …

[HTML][HTML] Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma: Complement-associated molecular features in …

R Huang, G Zhu, X Fu, W Liu, C Tao, J Gao… - Acta Biochimica et …, 2022 - ncbi.nlm.nih.gov
The complement cascade plays a “complementing” role in human immunity. However, the
potential roles of complement system in impacting molecular and clinical features of …

[PDF][PDF] The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of …

P Giuffrida, C Celsa, M Antonucci, M Peri, MV Grassini… - 2022 - academia.edu
Hepatocellular carcinoma (HCC) is a challenging malignancy characterised by clinical and
biological heterogeneity, independent of the stage. Despite the application of surveillance …

Molecular therapies and precision medicine for hepatocellular carcinoma

JM Llovet i Bayer, R Montal, D Sia… - … , 2018, vol. 15, p. 599-616, 2018 - diposit.ub.edu
The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass
an annual incidence of 1 million cases. Genomic studies have established the landscape of …